At this dinner you’ll

This Dinner You’ll Explore the Future of Accelerated CMC Development Bringing a new small molecule therapy from preclinical development to IND and beyond requires more than speed it demands a well coordinated CMC strategy that aligns scientific, analytical, and manufacturing activities from the earliest stages. At this exclusive, invitation only executive dinner hosted by Wilmington PharmaTech, senior leaders from CMC, Technical Operations, Process Development, and Manufacturing will come together to discuss practical strategies for accelerating development while maintaining regulatory compliance and product quality. This dinner you’ll: -Discover how integrated CMC planning can shorten development timelines by aligning solid state chemistry, analytical development, process optimization, and RSM production early in the program. -Learn practical approaches to accelerating IND enabling activities without compromising quality or regulatory expectations. -Gain insights into building resilient U.S. based API manufacturing strategies that improve supply chain reliability and support scalable GMP production. -Exchange experiences on managing compressed development timelines while balancing technical, regulatory, and commercial priorities. -Explore best practices for phase appropriate analytical controls, process development, and raw material planning that reduce downstream risks. -Connect with fellow pharmaceutical and biotech executives facing similar challenges in API development, manufacturing, and CMC execution. -Understand how integrated development and manufacturing models can improve readiness for clinical supply, reduce technology transfer risks, and support successful progression toward NDA submission. More than a technical discussion, this executive dinner provides a confidential setting for industry peers to exchange real world experiences, discuss emerging challenges, and identify practical solutions that can accelerate drug development while strengthening manufacturing resilience.

More about Wilmington PharmaTech

Founded in 2003 and based in Delaware, USA, Wilmington PharmaTech has been actively expanding and delivering API synthesis and other CMC (Chemistry, Manufacturing, and Controls) services: -GLP and cGMP synthesis (5 kilo labs with 100-200 L reactors and two pilot plant bays with up to 750 gallon reactors). We usually deliver 10-15 APIs for clinical use annually with 3-22 step synthesis procedures. -HPAPI facility with 2 GMP kilo labs certified for CPT below 10 ng/m3 and with milling capacity. – Solid state chemistry (salt screen, polymorph screen, particle size, single crystal, chiral salt screen, and crystallization for purification). -Brand new Purification and Chiral Separation Services: MedChem (mg-g scale), impurity isolation, comprehensive analysis. -Full analytical method validations, release tests, and ICH stability studies.-Sample storage services, including reference sample, and GMP API storage and distribution. -GTIs trace analysis. –www.wilmingtonpharmatech

More about Afton Scientific

Afton Scientific is a U.S.-based sterile injectable CDMO focused exclusively on aseptic fill/finish, with more than 20 years of experience supporting clinical and commercial programs for biologics and small molecules. The company provides flexible, scalable capacity across batch sizes and container formats to support evolving supply‑chain needs. Built around partnership, Afton offers a different way of managing relationships – one that emphasizes direct access to leadership, accountability, and integrated project execution rather than a traditional transactional CDMO model. This approach, combined with continuous investment in people, quality systems, and infrastructure, positions Afton as a long‑term fill/finish partner for complex sterile injectable programs. www.aftonscientific.com

More About AGC Biologics

AGC Biologics is a global CDMO headquartered in Seattle, Washington, providing pharmaceutical development and manufacturing services for protein-based biologics, cell and gene therapies, and messenger RNA. With multiple sites and teams of scientists across three continents, we have the resources and available capacity needed to accelerate your race to GMP. From development to clinical trials to full-scale commercialization, we can help you reach your goals at any stage in the drug development and manufacturing process. We specialize in mammalian and microbial-based therapeutic proteins, pDNA, mRNA, viral vectors, and engineered cells.

More about Afton Scientific

Afton Scientific is a U.S.-based sterile injectable CDMO focused exclusively on aseptic fill/finish, with more than 20 years of experience supporting clinical and commercial programs for biologics and small molecules. The company provides flexible, scalable capacity across batch sizes and container formats to support evolving supply‑chain needs. Built around partnership, Afton offers a different way of managing relationships – one that emphasizes direct access to leadership, accountability, and integrated project execution rather than a traditional transactional CDMO model. This approach, combined with continuous investment in people, quality systems, and infrastructure, positions Afton as a long‑term fill/finish partner for complex sterile injectable programs. www.aftonscientific.com

More about Agilisium

Agilisium is Life Sciences industry’s premier Agentic AI-powered Data Innovation partner. Agilisium collaborates with leading pharmaceutical, biotech and medical devices companies to provide data-driven insights and innovative solutions across the value chain accelerating scientific innovation, improving patient outcomes, and enhancing access to affordable care. The company delivers cutting-edge solutions that drive impactful change by combining our strong Life Sciences domain expertise with Data, Cloud, Agentic AI, and Advanced Analytics. Learn more at www.agilisium.com

More about Afton Scientific and West Pharmaceutical Services, Inc.

Afton Scientific is a U.S.-based CDMO with over 20 years of experience in the aseptic fill-finish of injectable drugs. We support both clinical and commercial programs, working across small and large molecules with the flexibility to meet unique project needs. Our customer-first approach and global regulatory compliance are rooted in responsiveness, transparency, and a culture of collaboration. With operational excellence and continuous improvement at our core, we’re proud to deliver dependable, flexible sterile manufacturing services that grow with our customers and the patients they serve. www.aftonscientific.com

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. www.westpharma.com

Why you should attend

We invite you to contribute your expertise to an exclusive boardroom discussion about AI-driven Drug Discovery. Join us to discuss how science and technology can advance discovery by using the virtual twin to accelerate drug design.

More about BIOVIA, Dassault Systèmes

BIOVIA, a brand of Dassault Systèmes, provides a scientific collaborative environment for advanced biological, chemical and materials experiences that allows science-driven companies access, organize, analyze and share data in unprecedented ways throughout the product lifecycle in regulated and non-regulated environments. BIOVIA’s sophisticated enterprise portfolio of Scientific Informatics, Molecular Modeling u0026amp; Simulation, Data Science, Laboratory Informatics, Formulation Design, Life Sciences Quality u0026amp; Compliance and Manufacturing Analytics helps drive innovation, increase productivity, improve quality and compliance,rnreduce costs and accelerate time to market. BIOVIA is committed to enhancing and speeding innovation, increasing productivity, improving quality and compliance, reducing costs and accelerating product development for pharma and biotech companies around the world.”

More about ESKO

Esko helps its customers make the best packaging for billions of consumers. Our product portfolio supports and manages the packaging and print processes for brands, retailers, designers, premedia and trade shops, packaging manufacturers, and converters. Esko solutions are used in product content and packaging management, asset management, artwork creation, structural design, prepress, 3D visualization, flexo plate making, workflow automation, quality assurance, samplemaking, palletization, supply chain collaboration and/or the production of signage and displays. www.esko.com

More about ESKO

Esko helps its customers make the best packaging for billions of consumers. Our product portfolio supports and manages the packaging and print processes for brands, retailers, designers, premedia and trade shops, packaging manufacturers, and converters. Esko solutions are used in product content and packaging management, asset management, artwork creation, structural design, prepress, 3D visualization, flexo plate making, workflow automation, quality assurance, sample-making, palletization, supply chain collaboration and/or the production of signage and displays. www.esko.com

More about ESKO

Esko helps its customers make the best packaging for billions of consumers. Our product portfolio supports and manages the packaging and print processes for brands, retailers, designers, premedia and trade shops, packaging manufacturers, and converters. Esko solutions are used in product content and packaging management, asset management, artwork creation, structural design, prepress, 3D visualization, flexo plate making, workflow automation, quality assurance, sample-making, palletization, supply chain collaboration and/or the production of signage and displays. www.esko.com